Literature DB >> 33947663

Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.

Subramanian Venkatesan1,2, Mihaela Angelova1, Clare Puttick1, Haoran Zhai2, Deborah R Caswell1, Wei-Ting Lu1, Michelle Dietzen1,2,3, Panagiotis Galanos4, Konstantinos Evangelou5, Roberto Bellelli6, Emilia L Lim1,2, Thomas B K Watkins1, Andrew Rowan1, Vitor H Teixeira7, Yue Zhao8,9,10,11, Haiquan Chen8,9,10,11, Bryan Ngo12, Lykourgos-Panagiotis Zalmas13, Maise Al Bakir1, Sebastijan Hobor1, Eva Grönroos1, Adam Pennycuick7, Ersilia Nigro7, Brittany B Campbell1, William L Brown14,15, Ayse U Akarca16, Teresa Marafioti16, Mary Y Wu17, Michael Howell17, Simon J Boulton18, Cosetta Bertoli19, Tim R Fenton20, Robertus A M de Bruin19, Apolinar Maya-Mendoza4, Eric Santoni-Rugiu21,22, Robert E Hynds1,2, Vassilis G Gorgoulis5,23,24,25, Mariam Jamal-Hanjani2,26, Nicholas McGranahan2,3, Reuben S Harris14,15,27, Sam M Janes7, Jirina Bartkova4,28, Samuel F Bakhoum29,30, Jiri Bartek31,28, Nnennaya Kanu32, Charles Swanton.   

Abstract

APOBEC3 enzymes are cytosine deaminases implicated in cancer. Precisely when APOBEC3 expression is induced during cancer development remains to be defined. Here we show that specific APOBEC3 genes are upregulated in breast ductal carcinoma in situ, and in preinvasive lung cancer lesions coincident with cellular proliferation. We observe evidence of APOBEC3-mediated subclonal mutagenesis propagated from TRACERx preinvasive to invasive non-small cell lung cancer (NSCLC) lesions. We find that APOBEC3B exacerbates DNA replication stress and chromosomal instability through incomplete replication of genomic DNA, manifested by accumulation of mitotic ultrafine bridges and 53BP1 nuclear bodies in the G1 phase of the cell cycle. Analysis of TRACERx NSCLC clinical samples and mouse lung cancer models revealed APOBEC3B expression driving replication stress and chromosome missegregation. We propose that APOBEC3 is functionally implicated in the onset of chromosomal instability and somatic mutational heterogeneity in preinvasive disease, providing fuel for selection early in cancer evolution. SIGNIFICANCE: This study reveals the dynamics and drivers of APOBEC3 gene expression in preinvasive disease and the exacerbation of cellular diversity by APOBEC3B through DNA replication stress to promote chromosomal instability early in cancer evolution.This article is highlighted in the In This Issue feature, p. 2355. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33947663      PMCID: PMC8487921          DOI: 10.1158/2159-8290.CD-20-0725

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  69 in total

1.  APOBEC3A can activate the DNA damage response and cause cell-cycle arrest.

Authors:  Sébastien Landry; Iñigo Narvaiza; Daniel C Linfesty; Matthew D Weitzman
Journal:  EMBO Rep       Date:  2011-04-01       Impact factor: 8.807

2.  Genomic characterization of metastatic breast cancers.

Authors:  François Bertucci; Charlotte K Y Ng; Anne Patsouris; Thomas Filleron; Christophe Le Tourneau; Fabrice André; Nathalie Droin; Salvatore Piscuoglio; Nadine Carbuccia; Jean Charles Soria; Alicia Tran Dien; Yahia Adnani; Maud Kamal; Séverine Garnier; Guillaume Meurice; Marta Jimenez; Semih Dogan; Benjamin Verret; Max Chaffanet; Thomas Bachelot; Mario Campone; Claudia Lefeuvre; Herve Bonnefoi; Florence Dalenc; Alexandra Jacquet; Maria R De Filippo; Naveen Babbar; Daniel Birnbaum
Journal:  Nature       Date:  2019-05-22       Impact factor: 49.962

3.  APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.

Authors:  Rémi Buisson; Michael S Lawrence; Cyril H Benes; Lee Zou
Journal:  Cancer Res       Date:  2017-07-11       Impact factor: 12.701

4.  Cytosine Deaminase APOBEC3A Sensitizes Leukemia Cells to Inhibition of the DNA Replication Checkpoint.

Authors:  Abby M Green; Konstantin Budagyan; Katharina E Hayer; Morgann A Reed; Milan R Savani; Gerald B Wertheim; Matthew D Weitzman
Journal:  Cancer Res       Date:  2017-06-27       Impact factor: 12.701

5.  Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo.

Authors:  Florence Debacq-Chainiaux; Jorge D Erusalimsky; Judith Campisi; Olivier Toussaint
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

6.  Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake.

Authors:  Sarah J Kemp; Andrew J Thorley; Julia Gorelik; Michael J Seckl; Michael J O'Hare; Alexandre Arcaro; Yuri Korchev; Peter Goldstraw; Teresa D Tetley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-06       Impact factor: 6.914

7.  Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers.

Authors:  Prokopios P Argyris; Peter E Wilkinson; Matthew C Jarvis; Kelly R Magliocca; Mihir R Patel; Rachel I Vogel; Rajaram Gopalakrishnan; Ioannis G Koutlas; Reuben S Harris
Journal:  Mod Pathol       Date:  2020-07-06       Impact factor: 7.842

8.  QuPath: Open source software for digital pathology image analysis.

Authors:  Peter Bankhead; Maurice B Loughrey; José A Fernández; Yvonne Dombrowski; Darragh G McArt; Philip D Dunne; Stephen McQuaid; Ronan T Gray; Liam J Murray; Helen G Coleman; Jacqueline A James; Manuel Salto-Tellez; Peter W Hamilton
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

9.  A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3B.

Authors:  William L Brown; Emily K Law; Prokopios P Argyris; Michael A Carpenter; Rena Levin-Klein; Alison N Ranum; Amy M Molan; Colleen L Forster; Brett D Anderson; Lela Lackey; Reuben S Harris
Journal:  Antibodies (Basel)       Date:  2019-09-10

10.  Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.

Authors:  Chai Yeen Goh; Boon Haow Chua; Pieter A Roelofs; Matthew C Jarvis; Teneale A Stewart; Jennifer L McCann; Rebecca M McDougle; Michael A Carpenter; John Wm Martens; Paul N Span; Dennis Kappei; Reuben S Harris
Journal:  Elife       Date:  2020-09-28       Impact factor: 8.140

View more
  11 in total

1.  An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.

Authors:  Jesse Boumelha; Sophie de Carné Trécesson; Emily K Law; Pablo Romero-Clavijo; Matthew A Coelho; Kevin W Ng; Edurne Mugarza; Christopher Moore; Sareena Rana; Deborah R Caswell; Miguel Murillo; David C Hancock; Prokopios P Argyris; William L Brown; Cameron Durfee; Lindsay K Larson; Rachel I Vogel; Alejandro Suárez-Bonnet; Simon L Priestnall; Philip East; Sarah J Ross; George Kassiotis; Miriam Molina-Arcas; Charles Swanton; Reuben Harris; Julian Downward
Journal:  Cancer Res       Date:  2022-10-04       Impact factor: 13.312

Review 2.  Exploiting the potential of lung stem cells to develop pro-regenerative therapies.

Authors:  Robert E Hynds
Journal:  Biol Open       Date:  2022-10-14       Impact factor: 2.643

3.  A pan-cancer compendium of chromosomal instability.

Authors:  Geoff Macintyre; Florian Markowetz; Ruben M Drews; Barbara Hernando; Maxime Tarabichi; Kerstin Haase; Tom Lesluyes; Philip S Smith; Lena Morrill Gavarró; Dominique-Laurent Couturier; Lydia Liu; Michael Schneider; James D Brenton; Peter Van Loo
Journal:  Nature       Date:  2022-06-15       Impact factor: 69.504

4.  Genomic instability genes in lung and colon adenocarcinoma indicate organ specificity of transcriptomic impact on Copy Number Alterations.

Authors:  Chinthalapally V Rao; Chao Xu; Yuting Zhang; Adam S Asch; Hiroshi Y Yamada
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

5.  SARS-CoV-2-induced senescence as a potential therapeutic target.

Authors:  Mary Denholm; Robert C Rintoul; Daniel Muñoz-Espín
Journal:  Eur Respir J       Date:  2022-08-18       Impact factor: 33.795

6.  B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.

Authors:  Zhiquan Wang; Huihuang Yan; Justin C Boysen; Charla R Secreto; Renee C Tschumper; Dania Ali; Qianqian Guo; Jian Zhong; Jiaqi Zhou; Haiyun Gan; Chuanhe Yu; Diane F Jelinek; Susan L Slager; Sameer A Parikh; Esteban Braggio; Neil E Kay
Journal:  Blood Cancer J       Date:  2022-07-01       Impact factor: 9.812

Review 7.  Cancer evolution: Darwin and beyond.

Authors:  Roberto Vendramin; Kevin Litchfield; Charles Swanton
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

8.  Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis.

Authors:  Konstantinos Evangelou; Dimitris Veroutis; Koralia Paschalaki; Periklis G Foukas; Nefeli Lagopati; Marios Dimitriou; Angelos Papaspyropoulos; Bindu Konda; Orsalia Hazapis; Aikaterini Polyzou; Sophia Havaki; Athanassios Kotsinas; Christos Kittas; Athanasios G Tzioufas; Laurence de Leval; Demetris Vassilakos; Sotirios Tsiodras; Barry R Stripp; Argyris Papantonis; Giovanni Blandino; Ioannis Karakasiliotis; Peter J Barnes; Vassilis G Gorgoulis
Journal:  Eur Respir J       Date:  2022-08-18       Impact factor: 33.795

Review 9.  Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination.

Authors:  Riccardo Pecori; Salvatore Di Giorgio; J Paulo Lorenzo; F Nina Papavasiliou
Journal:  Nat Rev Genet       Date:  2022-03-07       Impact factor: 59.581

10.  Pediatric chordoma associated with tuberous sclerosis complex: A rare case report with a thorough analysis of potential therapeutic molecular targets.

Authors:  Kirill Anoshkin; Denis Zosen; Kristina Karandasheva; Maxim Untesco; Ilya Volodin; Ekaterina Alekseeva; Anna Parfenenkova; Eugenia Snegova; Aleksandr Kim; Marina Dorofeeva; Sergei Kutsev; Vladimir Strelnikov
Journal:  Heliyon       Date:  2022-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.